Investigating the Role of Homoeopathy in Post Covid-19 Management.

Abstract

Viral pandemics, particularly COVID-19, have presented ongoing public health challenges, with the emergence of post-COVID-19 conditions, or long COVID, affecting a significant number of individuals. Characterized by persistent symptoms such as fatigue, dyspnea, and cognitive dysfunction, post-COVID-19 conditions require comprehensive treatment approaches. Homeopathy, a complementary medical system based on "like cures like," is being explored for its potential role in managing post-COVID-19 sequelae. The relationship between homeopathy and post-COVID-19 conditions is been discussed with the potential benefits of homeopathic remedies in symptom relief, immune support, and reducing fibrosis, which is closely associated with Transforming Growth Factor Beta (TGF-β) activity. TGF-β serves as a key marker for immune regulation and fibrotic processes, making it relevant in assessing the efficacy of homeopathic treatments. Randomized clinical trials (RCTs), which are crucial in validating homeopathy's effectiveness in treating long post-COVID-19, might play a major role in it. Additionally, the integration of Core Outcome Sets (COS) in clinical research aims to standardize outcome reporting and enhance the global understanding of homeopathic interventions for post-COVID-19 recovery. Homeopathy's holistic and individualized approach offers promise in improving patients' quality of life and supporting recovery from long-term COVID-19 effects, though further research is needed to solidify its role in post-COVID care.